Seltzer M - Search Results

1

Positron emission tomography in urologic oncology.

Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS. Shvarts O, et al. Among authors: seltzer m. Cancer Control. 2002 Jul-Aug;9(4):335-42. doi: 10.1177/107327480200900408. Cancer Control. 2002. PMID: 12228759 Free article. Review.

2

Emerging technologies in uroradiologic imaging.

Janzen NK, Laifer-Narin S, Han KR, Seltzer M, Thomas MA, Pantuck AJ, Belldegrun AS. Janzen NK, et al. Among authors: seltzer m. Urol Oncol. 2003 Sep-Oct;21(5):317-26. doi: 10.1016/s1078-1439(03)00061-9. Urol Oncol. 2003. PMID: 14670537 Review.

3

Positron emission tomography in urological oncology.

Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Hoh CK, et al. Among authors: seltzer ma. J Urol. 1998 Feb;159(2):347-56. doi: 10.1016/s0022-5347(01)63916-8. J Urol. 1998. PMID: 9649238 Review.

4

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.

Seltzer MA, Barbaric Z, Belldegrun A, Naitoh J, Dorey F, Phelps ME, Gambhir SS, Hoh CK. Seltzer MA, et al. J Urol. 1999 Oct;162(4):1322-8. J Urol. 1999. PMID: 10492189 Clinical Trial.

5

The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer.

Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. Safaei A, et al. Among authors: seltzer m. Clin Nephrol. 2002 Jan;57(1):56-62. doi: 10.5414/cnp57056. Clin Nephrol. 2002. PMID: 11837802

6

Evaluating tumor biology and oncological disease with positron-emission tomography.

Silverman DH, Hoh CK, Seltzer MA, Schiepers C, Cuan GS, Gambhir SS, Zheng L, Czernin J, Phelps ME. Silverman DH, et al. Among authors: seltzer ma. Semin Radiat Oncol. 1998 Jul;8(3):183-96. doi: 10.1016/s1053-4296(98)80044-1. Semin Radiat Oncol. 1998. PMID: 9634495 Review.

7

The impact of PET on the management of lung cancer: the referring physician's perspective.

Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. Seltzer MA, et al. J Nucl Med. 2002 Jun;43(6):752-6. J Nucl Med. 2002. PMID: 12050318 Free article.

8

Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.

Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J. Yap CS, et al. Among authors: seltzer ma. J Nucl Med. 2001 Sep;42(9):1334-7. J Nucl Med. 2001. PMID: 11535721 Free article.

9

The impact of 2-deoxy-2[18F] fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma: the referring physician's perspective.

Wong C, Silverman DH, Seltzer M, Schiepers C, Ariannejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J. Wong C, et al. Among authors: seltzer m. Mol Imaging Biol. 2002 Mar;4(2):185-90. doi: 10.1016/s1536-1632(01)00003-8. Mol Imaging Biol. 2002. PMID: 14537142

10

Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.

Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. Meta J, et al. Among authors: seltzer m. J Nucl Med. 2001 Apr;42(4):586-90. J Nucl Med. 2001. PMID: 11337546 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters